B., McCuen-Wurst, C., Jones, E., McAllister, C., Gruber, K., Berkowitz, R
J Biol Chem 257:99099912 Mannervik B, Danielson UH (1988) Glutathione transferasesstructure and catalytic activity
Choi_ Nikolai stock.adobe.com News Weight loss and diabetes medication GLP-1 agonists may interfere with cancer imaging, new study finds The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET/CT scans, new research presented at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM'25) has revealed. GLP-1 receptor agonists are now widely prescribed for individuals with type 2 diabetes and weight loss, with a 700% increase in usage reported in the United States between 2019 and 2023
Specifically, Shih et al
Native and stable in human gastric juice, BPC-157 helps maintain gastrointestinal mucosal integrity and has been studied as safe in inflammatory bowel disease trials
BPC-157 is one of the most extensively investigated cytoprotective research peptides, with a preclinical literature spanning over a hundred studies on tendon, ligament, muscle, gastric, and nerve models
